332
Views
8
CrossRef citations to date
0
Altmetric
Drug Profile

Guanfacine for the treatment of attention deficit hyperactivity disorder in children and adolescents

&

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Isabella Berardelli, Massimo Pasquini, Antonella Conte, Matteo Bologna, Alfredo Berardelli & Giovanni Fabbrini. (2019) Treatment of psychiatric disturbances in common hyperkinetic movement disorders. Expert Review of Neurotherapeutics 19:1, pages 55-65.
Read now
Nicholas T Bello. (2015) Clinical utility of guanfacine extended release in the treatment of ADHD in children and adolescents. Patient Preference and Adherence 9, pages 877-885.
Read now

Articles from other publishers (6)

Elena Cichero, Valeria Francesconi, Beatrice Casini, Monica Casale, Evgeny Kanov, Andrey S. Gerasimov, Ilya Sukhanov, Artem Savchenko, Stefano Espinoza, Raul R. Gainetdinov & Michele Tonelli. (2023) Discovery of Guanfacine as a Novel TAAR1 Agonist: A Combination Strategy through Molecular Modeling Studies and Biological Assays. Pharmaceuticals 16:11, pages 1632.
Crossref
Robert L. FindlingLenard A. AdlerThomas J. SpencerRobert GoldmanSeth C. HopkinsKenneth S. KoblanJustine KentJay HsuAntony Loebel. (2019) Dasotraline in Children with Attention-Deficit/Hyperactivity Disorder: A Six-Week, Placebo-Controlled, Fixed-Dose Trial. Journal of Child and Adolescent Psychopharmacology 29:2, pages 80-89.
Crossref
David B. Bylund. 2018. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Alexander K.C. Leung & Kam Lun Hon. (2016) Attention-Deficit/Hyperactivity Disorder. Advances in Pediatrics 63:1, pages 255-280.
Crossref
Jatinder Singh & Paramala Santosh. 2016. Child and Adolescent Psychiatry. Child and Adolescent Psychiatry 325 362 .
Davide Martino, Alberto J. Espay, Alfonso Fasano & Francesca MorganteDavide Martino, Alberto J. Espay, Alfonso Fasano & Francesca Morgante. 2016. Disorders of Movement. Disorders of Movement 97 153 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.